Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

FEBS Letters

Volumn 475, Issue 2, 2000, Pages 150-156

  Serradeil Le Gal, Claudine ^a   Lafontan, Max ^b   Raufaste, Danielle ^a   Marchand, Jean ^a   Pouzet, Brigitte ^a   Casellas, Pierre ^a   Pascal, Marc ^a   Maffrand, Jean Pierre ^a   Le Fur, Gérard ^a  

^a SANOFI   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Human adipocyte; Leptin; Lipolysis; Neuropeptide Y; Neuropeptide Y Y1 receptor; Peptide YY

Indexed keywords

GENE EXPRESSION MODULATOR 132; LEPTIN; N [1 [4 [[[[4 [(DIMETHYLAMINO)METHYL]CYCLOHEXYL]METHYL]AMINO]IMINOMETHYL]BENZYL] 2 OXO 2 (1 PYRROLIDINYL)ETHYL] ALPHA [(2 NAPHTHALENYLSULFONYL)AMINO]BENZENEPROPANAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; PEPTIDE YY; RECEPTOR SUBTYPE;

ADIPOCYTE; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOCYTES; ADULT; ARGININE; BINDING SITES; CELL MEMBRANE; CELLS, CULTURED; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LEPTIN; LIGANDS; LIPOLYSIS; MIDDLE AGED; NAPHTHALENES; PEPTIDES; PROTEIN BINDING; PYRROLIDINES; RECEPTORS, NEUROPEPTIDE Y; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0034674764     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01649-5     Document Type: Article

References (23)

1. Tatemoto K. Proc. Natl. Acad. Sci. USA. 79:1982;5485-5489.
2. Michel M., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. Pharmacol. Rev. 50:1998;143-150.
3. Castan I., Valet P., Voisin T., Quidau N., Laburthe M., Lafontan M. Endocrinology. 131:1992;1970-1976.
4. Castan I., Valet P., Larrouy D., Voisin T., Remaury A., Daviaud D., Laburthe M., Lafontan M. Am. J. Physiol. 265:1993;E74-E80.
5. Laburthe M., Chenut B., Rouyer-Fessard C., Tatemoto K., Couvineau A., Servin A., Amiranoff B. Endocrinology. 118:1986;1910-1917.
6. Voisin T., Bens M., Cluzeaud F., Vandewalle A., Laburthe M. J. Biol. Chem. 268:1993;20547-20554.
7. Labelle M., Boulanger Y., Fournier A., St-Pierre S., Savard R. Peptides. 18:1997;801-808.
8. Serradeil-Le Gal C., Valette G., Rouby P.-E., Pellet A., Oury-Donat F., Brossard G., Lespy L., Marty E., Neliat G., de Cointet P., Maffrand J.-P., Le Fur G. FEBS Lett. 362:1995;192-196.
9. Rudolf K., Eberlein W., Engel W., Wieland H.A., Willim K.D., Wienen W., Beck-Sickinger A.G., Doods H.N. Eur. J. Pharmacol. 271:1994;R11-R13.
10. Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Eur. J. Biochem. 232:1995;5-61.
11. Rodbell M. J. Biol. Chem. 239:1964;375-380.
12. Valet P., Berlan M., Beauville M., Crampes F., Montastruc J.-L., Lafontan M. J. Clin. Invest. 85:1990;291-295.
13. Bradford M.M. Anal. Biochem. 72:1976;248-254.
14. Munson P.V., Rodbard D. Anal. Biochem. 107:1980;220-239.
15. Bradley D.C., Kaslow H.R. Anal. Biochem. 180:1989;11-16.
16. Halvorsen Y.-D.C., Pingerelli P., Petre M.C., Saladin R., Briggs M.R. Strategies. 11:1999;58-60.
17. Dumont Y., Jacques D., Bouchard P., Quirion R. J. Comp. Neurol. 402:1998;372-384.
18. Widdowson P.S. Brain Res. 631:1993;27-38.
19. Doods H.N., Krause J. Eur. J. Pharmacol. 204:1991;101-103.
20. Lafontan M., Berlan M. Endocr. Rev. 16:1995;716-738.
21. Pedrazzini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., Brunner H. Nature. 6:1998;722-726.
22. Sliecker L.J., Sloop K.W., Surface P.L., Kriauciunas A., La Quier F., Manetta J., Bue-Valleskey J., Stephens T.W. J. Biol. Chem. 271:1996;5301-5304.
23. Getty T.W., Harkness P.J., Watson P.M. Endocrinology. 137:1996;4054-4057.